Cost-effectiveness of tenofovir prophylaxis during pregnancy for the elimination of mother-to-child transmission of the hepatitis B virus: real-world analysis from Thailand

Cost-effectiveness of tenofovir prophylaxis during pregnancy for the elimination of mother-to-child transmission of the hepatitis B virus: real-world analysis from Thailand

<h4>Objective</h4>Despite implementing hepatitis B immunoglobulin (HBIG) and vaccination, data suggest it would not be sufficient to reach the elimination targets. Tenofovir disoproxil fumarate (TDF) has been added to the Thai national standards of care for prevention of...

Full description

Bibliographic Details
Main Authors:	Janekrongtham, C, Punsuwan, N, Thitichai, P, Lertpiriyasuwat, C, Pan-Ngum, W, Poovorawan, K, Jantarapakde, J, Tangkijvanich, P
Format:	Journal article
Language:	English
Published:	BMJ Publishing Group 2023

Similar Items

Cost-effectiveness of tenofovir prophylaxis during pregnancy for the elimination of mother-to-child transmission of the hepatitis B virus: real-world analysis from Thailand
by: Jureeporn Jantarapakde, et al.
Published: (2023-07-01)

Tenofovir prophylaxis during pregnancy for the elimination of mother-to-child transmission of hepatitis B virus: a cost-effectiveness analysis
by: Janekrongtham, C, et al.
Published: (2023)

Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: a cost-effectiveness analysis
by: Bierhoff, M, et al.
Published: (2021)

Challenges of implementing tenofovir disoproxil fumarate in pregnancy for prevention of hepatitis B mother to child transmission in a rural population
by: Bierhoff, M, et al.
Published: (2020)

Tenofovir for prevention of mother to child transmission of hepatitis B in migrant women in a resource-limited setting on the Thailand-Myanmar border: a commentary on challenges of implementation
by: Bierhoff, M, et al.
Published: (2020)

Prevention of mother-to-child transmission of hepatitis B virus: protocol for a one-arm, open-label intervention study to estimate the optimal timing of tenofovir in pregnancy
by: Bierhoff, M, et al.
Published: (2020)

Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa
by: Mokaya, J, et al.
Published: (2019)

Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin Tissue
by: Laura Else, et al.
Published: (2022-06-01)

The road to eliminate mother‐to‐child HIV transmission
by: Andrew M. Redmond, et al.
Published: (2015-11-01)

WAYS TO ELIMINATION OF MOTHER-TO-CHILD TRANSMISSION OF HIV
by: N. V. Kozyrina, et al.
Published: (2018-12-01)

Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV
by: Inès Devred, et al.
Published: (2023-09-01)

Clinical trial simulation to evaluate tenofovir disoproxil fumarate/emtricitabine HIV pre-exposure prophylaxis dosing during pregnancy
by: Rachel K. Scott, et al.
Published: (2023-09-01)

Eliminating mother-to-child HIV transmission in South Africa
by: Peter Barron, et al.
Published: (2013-01-01)

Estimating the impact of expanding treatment coverage and allocation strategies for chronic hepatitis C in a direct antiviral agent era
by: Poovorawan, K, et al.
Published: (2016)

Tenofovir in the Management of Chronic Hepatitis B Infection During Pregnancy
by: Yeşim Çekin, et al.
Published: (2012-06-01)

Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study.
by: Rujipat Wasitthankasem, et al.
Published: (2018-01-01)

Cuba eliminates mother-to-child transmission of HIV and congenital syphilis
by: Mary L. Kamb, et al.
Published: (2022-04-01)

Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy
by: Hsin-Wei Fang, et al.
Published: (2024-04-01)

Leveraging geo-referenced malaria information to increase domestic financial support for malaria elimination in Thailand
by: Prayuth Sudathip, et al.
Published: (2022-07-01)

Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia.
by: Rujipat Wasitthankasem, et al.
Published: (2015-01-01)

RHD elimination: action needed beyond secondary prophylaxis
by: Kate Hardie, et al.
Published: (2020-10-01)

Biphasic Elimination of Tenofovir Diphosphate and Nonlinear Pharmacokinetics of Zidovudine Triphosphate in a Microdosing Study
by: Chen, Jianmeng, et al.
Published: (2014)

Reply to: “Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?”
by: Philippa C. Matthews, et al.
Published: (2023-11-01)

Awareness, knowledge, and practice for hepatitis B infection in Southeast Asia: a cross-sectional study.
by: Soe, KP, et al.
Published: (2019)

Awareness, knowledge and treatment acceptance of hepatitis B infection in Southeast Asia: a cross‐sectional study
by: Soe, KP, et al.
Published: (2017)

Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?
by: Yi-Hua Zhou, et al.
Published: (2023-11-01)

Characteristics and outcomes of cholangiocarcinoma by region in Thailand: A nationwide study
by: Chaiteerakij, R, et al.
Published: (2017)

Elimination of mother-to-child transmission of HIV, syphilis and viral hepatitis B: A call for renewed global focus
by: Ali Elgalib, et al.
Published: (2023-02-01)

Pharmacokinetics of oral tenofovir disoproxil fumarate in pregnancy and lactation: A systematic review
by: Bierhoff, M, et al.
Published: (2019)

Evaluating elimination of mother-to-child transmission of HIV in Suriname: a mixed method study
by: Deborah Stijnberg, et al.
Published: (2023-12-01)

Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
by: Aida N. Kawuma, et al.
Published: (2023-06-01)

Burden of liver abscess and survival risk score in Thailand: a population-based study
by: Poovorawan, K, et al.
Published: (2016)

Treatment of Chronic Hepatitis B with Tenofovir
by: Mohsen Akhondi Meybodi, et al.
Published: (2018-07-01)

Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
by: Hyeyeon Hong, et al.
Published: (2024-01-01)

Renal impairment associated with tenofovir disoproxil fumarate for antiretroviral therapy and HIV pre-exposure prophylaxis: An observational cohort study.
by: Jack E Heron, et al.
Published: (2023-01-01)

Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01
by: Yunda Huang, et al.
Published: (2023-11-01)

Regional differences in admissions and treatment outcomes for hepatocellular carcinoma patients in Thailand
by: Kitiyakara, T, et al.
Published: (2022)

Eliminating mother-to-child transmission of hepatitis B virus: practice and progress in Baoan, a national pilot district of China
by: Ya-Li Luo, et al.
Published: (2024-01-01)

Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients
by: Yim HJ, et al.
Published: (2022-09-01)

Subnational certification of elimination of mother-to-child transmission of HIV and/or syphilis: a Brazilian experience report
by: Angélica Espinosa Miranda, et al.
Published: (2023-10-01)